Area of research
Nephrology · Hematology
Research interest
Research interests include Renal Diseases and Glomerulopathies, Chronic Kidney Disease and Diabetes, Parathyroid Disorders and Treatments, and Dialysis and Renal Disease Management.
A meta-analysis of albuminuria as a surrogate endpoint for kidney failure
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy
Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group
Physical exercise in haemodialysis patients: which type of exercise is more convenient?
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
IgA nephropathy: the lectin pathway and implications for targeted therapy
International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD
Association of mineral and bone biomarkers with adverse cardiovascular outcomes and mortality in the German Chronic Kidney Disease (GCKD) cohort
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD
Differential Prognostic Utility of Adiposity Measures in Chronic Kidney Disease
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids
Deep learning-based classification of kidney transplant pathology: a retrospective, multicentre, proof-of-concept study
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis
Non-invasive molecular imaging of kidney diseases
Recommendations for the use of COVID-19 vaccines in patients with immune-mediated kidney diseases
Urine Metabolite Levels, Adverse Kidney Outcomes, and Mortality in CKD Patients: A Metabolome-wide Association Study
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression
Rationale and design of XARENO: XA inhibition in RENal patients with non-valvular atrial fibrillation. Observational registry
Directional Stochastic Orders with an Application to Financial Mathematics
Decoding myofibroblast origins in human kidney fibrosis
After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy
Identifying Outcomes Important to Patients with Glomerular Disease and Their Caregivers
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials